- ARK Invest’s actively-managed ETFs saw remarkable outperformance in 2020.
- So far in 2021, their performance has been lackluster.
- According to some experts, the funds won’t be able to match their 2020 returns going forward.
Five of Ark’s actively managed exchange-traded funds were up more than 100% in 2020, with the ARK Genomic Revolution ETF (ARKG) outperforming them all, returning 185%.
But 2021 is a different story so far. Though Wood said herself in a December interview with Bloomberg that she expects yearly returns in the low 20s in percentage terms over the next half-decade, four out of the firm’s largest funds by managed assets are negative since January 1, with the ARK Fintech Innovation ETF (ARKF) being the only exception.
Word abonnee van Business Insider